Christopher Mutz - Feb 28, 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF RARE DISEASE
Signature
/s/ Christopher Mutz, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Feb 28, 2025
Transactions value $
-$78,910
Form type
4
Date filed
3/4/2025, 05:12 PM
Previous filing
Feb 18, 2025
Next filing
Mar 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$78.9K -1.28K -1.1% $61.89 114K Feb 28, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported.